.Merck trumps revenues expectations, raises purchases expectation on powerful need for leading medicines like Keytruda CNBCMerck & Co. (MRK United States) Trumps Income Estimates as Keytruda Purchases Growth BloombergMerck Inventory: Pharma Titan Posts Tough Outcomes, Yet Overview Drops Short Entrepreneur's Organization DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats profit and purchases expectations among Keytruda advantage, however provides mixed full-year outlook MarketWatch.